Fukuoka, Japan

Tokuhiro Tamura

This inventor holds 1 USPTO granted patent and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mitsubishi Pharma Corporation, Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tokuhiro Tamura. Retrieved from https://idiyas.com/inventor/tokuhiro-tamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tokuhiro Tamura: Innovator in Pharmaceutical Compositions

Introduction

Tokuhiro Tamura is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions.

Latest Patents

Tamura holds a patent for a solid pharmaceutical composition comprising a SIP receptor agonist and a sugar alcohol. This innovative formulation is designed for oral administration, enhancing the delivery and efficacy of pharmaceutical agents.

Career Highlights

Throughout his career, Tokuhiro Tamura has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Tamura has collaborated with esteemed colleagues such as Tomoyuki Oomura and Madhusudhan Pudipeddi. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Tokuhiro Tamura's work in pharmaceutical innovations exemplifies the impact of dedicated inventors in the healthcare sector. His contributions continue to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…